Luigi Costa, Noema Pharma CEO

Noe­ma Phar­ma rais­es $112M Se­ries B to ad­vance CNS dis­or­der pipeline with Roche can­di­dates

Swiss biotech Noe­ma Phar­ma jump­start­ed back in 2020 with a $60 mil­lion Se­ries A fi­nanc­ing round. To­day, it’s wrap­ping up its Se­ries B round with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.